Lupin receives a satisfactory EIR from the USFDA for its Goa manufacturing plant, ensuring quality and compliance.
New Delhi
Drug maker Lupin on Friday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Goa-based manufacturing facility.
The company said it has rec… [+678 chars]









